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Molecular Dosimetry of DNA and
Hemoglobin Adducts in Mice and Rats
Exposed to Ethylene Oxide
by Vernon E. Walker,"23 Timothy R. Fennell,' Patricia
B. Upton,4 John R MacNeela,' and James A.
Swenberg4
Experimentsinvolvingethyleneoxide (ETO)havebeenusedtosupporttheconceptofusingadductsin hemoglobin as
a surrogate forDNA adducts in target tissues. The relationship between repeated exposuresto ETOand theformation
ofN-(2-hydroxyethyl)valine (HEtVal) inhemoglobin and7-(2-hydroxyethyl)guanine (7-HEG)inDNA wasinvestigatedin
male ratsand miceexposedby inhalation toO,3,10,33, or 100 ppmETOfor6hr/dayfor4weeks, orexposedto 100 ppm
(mice) or300 ppm(rats) for 1,3, 5,10, or20days(5days/week). HEtVal wasdetenninedby Ednandegradation, and7-HEG
wasquantitatedbyHPLC separationandfluorescence detection. HEtValformation was linearbetween3and33 ppmET1O
andincreased inslopeabove33 ppm. Thedose-response curvesfor7-HEGin rattissues werelinearbetween 10and 100
ppm ETOandincreased inslopeabove 100 ppm. Incontrast, only exposuresto 100 ppmETO resulted insignificant ac-
cumulation of7-HEG inmice. Hemoglobinadducts were lostat agreaterratethanpredictedbynormalerythrocyte life
span. The lossof7-HEG from DNA was both species andtissuedependent, with the adduct half-lives ranging from2.9
to5.8days in rattissues (brain,kidney, liver, lung, spleen, testis) and 1.0to2.3days inall mousetissues exceptkidney(tlm
= 6.9 days). Theconcentrations ofHEtVal weresimilarinconcurrently exposed ratsand mice, whereas DNA from rats
had at least2-fold greaterconcentrationsof7-HEGthanDNAfrom mice. Due to differencesinformation, persistence,
repair, and chemical depurination, the relationships betweenHEtVal and 7-HEG concentrations varied with length of
exposure, interval since exposure, species, andtissue. Thus, it appears unlikely thatHEtValadducts inhemoglobin will
provide accurate predictionsofDNAadductsinspecifictissuesofhumansunderconditionswhereactual exposurescenarios
are unknown.
Introduction
Ethylene oxide (ETO) is a potent mutagen and carcinogen in
laboratory animals, butitspotential to cause cancerin man is still
uncertain. In carcinogenicity bioassays, ETO caused dose-
related increases in the incidence ofgliomas, peritoneal meso-
theliomas, and mononuclear cell leukemias in F344 rats (1,2)
and lymphomas and adenomas/adenocarcinomas of the lung,
uterus, harderian gland, and mammary gland in B6C3F, mice
(3). In the earliest epidemiology studies on ETO and cancer,
Hogstedt et al. (4-7) reported excesses of leukemia and lym-
phatic and stomach cancers among sterilant workers and
employees in a chemical production plant. More recently, two
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independent studies found an excess of non-Hodgkin's lym-
phoma in ETO workers (7,8). Several other epidemiological
studieshavenotdemonstratedanyassociationbetweenETOex-
posureand cancerinworkers (10-12). However, thesensitivity
ofepidemiologic studiesdesignedtoassessthepotential health
hazardsofenvironmental chemicals is seriously compromised
by the lackofreliablequantitative exposuredataforindividuals
inexposedpopulations (13). Consequently, amajorgoal in the
studyofenvironmentalcarcinogens istoidentifybiomarkersthat
aresuitablefordetermining dose-response relationships in ex-
posed humans.
Because genetic damage and mutation are thought to play a
critical roleinchemicalcarcinogenesis, damagetoDNAcanbe
used asaninternal moleculardosimeterofcarcinogenexposure
[forreview seeSwenbergetal. (14)]. Therefore, DNA adducts
oravalidatedsurrogate arerelevant indicators ofthebiologically
effective dose (molecular dose) of carcinogen. Evaluation of
thesepotentialbiomarkersoverabroaddoserangeinexperimen-
tal animals offers a means of critically assessing which bio-
markers will be useful for monitoring human exposure and for
enhancing riskextrapolation across species.
A major initiative in monitoring carcinogen exposure came
from Ehrenbergandhis co-workers, who suggestedmeasuringWALKER ETAL.
adducts inhemoglobin asasurrogateforthemolecular doseof
adducts in DNA (15,16). However, asnotedby Wogan (17), in-
formation concerning interrelationships betweenthe formation
of DNA and hemoglobin adducts is very limited, and studies
designed to evaluate these relationships are needed. Thus far,
mostanimalexperimentsinvestigatingtheserelationships have
used single doses ofcarcinogen (18).
Several experiments involving ETOhavebeenusedtosupport
the concept ofusing adducts in hemoglobin as a surrogate for
DNA adducts in target tissues. However, previous studies in-
vestigating theformationofbothhemoglobinandDNAadducts
haveusedonly singleexposuresofrats(19,20) andmice(21) to
ETO. The data from these studies showed a constant ratio be-
tween DNAandhemoglobinalkylation overtherangeofdoses
ofETO investigated, supporting the suggestion that the deter-
mination ofthehemoglobin dosein vvoisavalidindicatorofthe
doseto DNAintargettissues(20). However, manyDNAadducts
canbe lostby processes such as repair and chemical depurina-
tion (14), whereas hemoglobin adducts of ETO appear to be
stable. Therefore, itisessential toexaminetherelationshipsbet-
ween hemoglobin and DNA adduct formation in rats and mice
overarangeofexposuresandtimesofexposuretoETO(22-24).
Themoleculardosimetrystudies reviewedheredemonstratethat
theratiosbetween DNAandhemoglobinadductconcentrations
changeovertimeduringrepeatedexposurestoETOandthatthe
natureoftherelationshipbetweenDNAandhemoglobinalkyla-
tionisbothtissueandspeciesdependentduetodifferencesinthe
life span ofthe erythrocyte anddifferences in DNA repair.
Methods
Themethodological details ofthese investigations havebeen
publishedelsewhere(22-24). Thus, only abriefsummaryofthe
methods is given here.
Animal Exposures
Groupsof9-week-oldmaleB6C3FI miceandF344 rats were
exposedin8-m3 stainless-steel andglassinhalationchambersto
0, 3, 10, 33, or 100 ppm ETO for 6 hr/day for 4 weeks (5 days/
week), orexposedto 100ppm(mice)or300ppm(rats)ETOfor
1, 3, 5, 10, or 20 days (5 days/week). In the dose-response
studies, themiceandratswereexposedconcurrently inthesame
exposurechambers. TheETOconcentration insideeachcham-
ber was monitored continuously using a Miran infrared spec-
trophotometer. At necropsy of treated and control animals,
heparinizedblood wastakenfromeachanimalbycardiacpunc-
tureandredbloodcellswerewashedwithisotonicsaline, frozen,
and stored at-20°Cuntilglobin samples wereisolated. Brains,
kidneys, leukocytes (300 ppm ETO-treated rats only), livers,
lungs, spleens, and testes were removed, frozen, and stored at
-20°C until the DNA was isolated.
Assay for N-(2-Hydroxyethyl)valine
Erythrocytes from individual animals werelysed, andglobin
was isolatedbyextractionwithacidic isopropanolandprecipita-
tionwithethylacetate(23,25).N-(2-Hydroxyethyl)valine(HEt-
Val) in globin samples from control and treated animals was
determined by a modified Edman degradation and GC-MS
quantitation of its pentafluorophenylisothiocyanate derivative
(26). Additionofaknownamountof[2H4]ethyleneoxide-treated
globinasaninternal standard, priortoEdmandegradation, pro-
videdameans forquantitationoftheamountofHEtValpresent
in the isolated globin samples. Derivatized samples were
analyzed by GC-MS in the negative ion chemical ionization
modeusingaFinnigan4500GC-MS instrumentequippedwith
anon-column injectorandaDB-5 column, withmethaneasthe
reagentgas. Them/z348andm/z352weremonitoredfordetec-
tionoftheanalyteandinternal standard, respectively. Quantita-
tion wasbasedoncomparisonofthepeakareaoftheanalyte to
thatoftheinternalstandardandcomparisontoacalibrationcurve
for HEtVal inglobin.
Assay for 7-(2-Hydroxyethyl)guanine
Wholetissues from individual ratsor sets offour mice were
homogenized, and DNA was isolatedusing an automated phe-
nolicextractionprocedure(22,24). DNAsamplesfromratsex-
posed to 300 ppm ETO were analyzed for 7-(2-hydroxyethyl)-
guanine (7-HEG) using neutral thermal hydrolysis and acid
precipitation, cation-exchange HPLC separation, and fluo-
rescencedetection (22). Thedetectionlimitfortheassay was20
pmole 7-HEG/mg DNA.
The assay for 7-HEG was subsequently improved by using
selective enrichment via Centricon 30 microconcentrators
(Amicon, Danvers, MA) inplace ofacid precipitation, and by
developing anew chromatography system (24). The improved
assay was used to analyze DNA from animals in the dose-
response studiesandthemousetime-course study. Upto2 mL
of each thermal hydrolysate was cooled to 4°C and filtered
through aCentricon 30bycentrifugation. TheDNAbackbone
was retained on the Centricon 30 ultrafiltration membrane
(30,000 molecular weight cutoff), and essentially 100% ofthe
7-HEGwasrecovered inthefiltrate. Thefiltrateswerereduced
to a 1.0-mL injection volume and chromatographed using a
hybrid RP-SCX column (250 x 5.6 mm, 60 A, 5 ym, lot no.
1990055VW; ES Industries, Marlton, NJ) eluted with 80 mM
ammoniumformate, pH2.8, with50 % acetonitrile. 7-HEG was
quantifiedbymeasuring fluorescenceintensity (excitation at295
nm and emission at 370 nm) and comparing peak areas to a
calibrationcurvefor7-HEGstandard. Thedetectionlimitofthis
assay was 2 pmole 7-HEG/mg DNA.
Resultsand Discussion
Analysisofglobinfromcontrolanimals showedbackground
concentrations ofHEtVal averaging 42 ± 8 and 58 ± 10 (SE)
fmole adduct/mg globin in rats and mice, respectively, while
analyis ofDNA from control tissues revealed the presence of
peaks equivalent to 2-5 pmole 7-HEG/mg DNA. The 7-HEG
standardcoelutedwiththesepeaks,givingsimilarconcentrations
using standardadditions. Comparableconcentrations ofHEtVal
inhemoglobin (26) and7-HEG inlymphocytes (27) havebeen
found in control populations of humans and experimental
animalswithoutknownexposuretohydroxyethylatingagentsor
any obviousprecursor.
Repeated exposuresofratsandmicetoETOledtoaccumula-
tionofHEtVal inhemoglobinand7-HEGinDNAofalltissues
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examined. After4weeksofexposure,thedose-responserelation-
shipsforHEtValand7-HEGwerenonlinearinbothratsandmice.
Thedose-responsecurvesforHEtValwerelinearbetween3and
33 ppm ETOand increased in slopeabove 33 ppm(Fig. 1). The
concentrations ofHEtVal were similarinconcurrently exposed
rats and mice. A comparison ofthe dose-response curves for
7-HEGinDNAofbothspeciesshowedthatratshadsignificant-
ly greater accumulations of 7-HEG than those in similarly
exposed mice(Fig. 2). Inrats,thedose-responsecurvefor7-HEG
waslinearbetween 10and 100ppmETO(Fig. 2)andincreasedin
slopeabove 100ppm(seeFig. 6A). Incontrast, after4weeksofex-
posureofmiceto 10and33ppmETO,theconcentrationsof7-HEG
weresimilartoandjustabove,respectively,thoseconcentrations
foundincontrolmousetissues(Fig.2).Repeatedexposuresto 100
ppmETOwererequiredtodemonstrateanysignificantaccumula-
tionof7-HEGinmousetissues.
Exposures ofrats and mice for4 weeks (5 days/week) to 300
and 100ppmETO, respectively, ledtoanaccumulationofHEt-
Val thatwas 14 (rats)and 15 (mice)timesgreaterthanthatfound
afterasingledayofexposure (Fig. 3). Aftercessationofthetime-
course studies, HEtVal was lost more rapidly than would be
predicted by the normal erythrocyte life span in rats and mice
(Fig. 4). Theinitial phaseofrapiddecline in HEtVal concentra-
tions in exposed rats (Fig. 4A) was consistent with the removal
ofolder, moreheavily alkylatedpopulations ofredbloodcells,
accompaniedby aburstoferythropoiesis. Moreover, evaluation
oftheprotocolsused inthesestudies revealedthatdiscontinuous
exposures toETO can result incomplexpatternsofhemoglobin
adductremoval (23,28), incontrasttothepredictablepatternsof
adductremoval observedaftersingleexposures orexposures ex-
ceeding the life span oferythrocytes (29).
Accumulations of7-HEGweresimilarintargetandnontarget
tissues within each species, with the exception that the
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FIGURE 1. Dose response forN-(2-hydroxyethyl)valine inhemoglobin ofmice
(*)andrats (*)after4weeks (6hr/day, 5days/week)ofexposures toethylene
oxide. Data points are means ± SE (n = 5).
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FIGURE 2. Dose response for 7-(2-hydroxyethyl)guanine in DNA of rats
(A brain, 0 lung, Ol spleen) and mice (A brain, * lung, *spleen) after4
weeks (6hr/day, 5days/week) ofexposures toethyleneoxide. Datapointsare
means ± SE (n = 4).
adduct concentration in testis was 50-70% and 35-47% lower
thaninotherratand mousetissues, respectively (Fig. 3). After
cessation ofexposures, two distinct patterns of7-HEG persis-
tencewereapparentamongtheratandmousetissuesinvestigated
(Fig. 5). 7-HEGdisappearedinaslow, steady fashionfromDNA
ofmousekidney (tl/2 = 6.9 days) and ratlung, brain, and testis
4t/2 = 4.8-5.8 days), consistent with adduct loss primarily by
chemicaldepurination(24). Incontrast, thelossof7-HEGfrom
other mouse (t12 = 1.0-2.3 days) and rat (t412 = 2.9-3.9 days)
tissues wasmorerapid, consistentwithlossby acombinationof
depurination and active removal of adducts by DNA repair.
Finally, acomparisonofthedose-response, formation, andper-
sistence curves for each species indicated that saturation of
7-HEGrepairhadoccurredattheconcentrationsofETXOusedin
the time-course studies. Furthermore, the occurrence ofnon-
lineardose-responsecurves suggestedthatrepeatedexposures
ofrats and mice to lowerconcentrations ofETO, matching the
linearportionsofthecurves, wouldleadtospeciesandtissuedif-
ferences in 7-HEG accumulation as a result ofdifferences in
DNA repair.
DNAand Hemoglobin AdductsAs
MolecularDosimetersafter Repeated
IntermittentExposurestoETO
ThenatureoftherelationshipsbetweentheformationofHEt-
Val in hemoglobin and 7-HEG in DNA during repeated ex-
posures ofrats andmice toETXO was revealed, inpart, by com-
parisonsoftheshapesoftheformationcurves fortheseadducts
in each species (Fig. 3). The shape ofthe formation curve for
HEtVal in rats exposed to 300 ppm ETO indicated that the
hemoglobinadductshouldaccumulatewellbeyond4weekswith
continued exposures totheepoxide. Theseresults areconsistent
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hemoglobinand 7-HEG in DNAchanged throughoutrepeated
exposuresofratstoETO. Over4weeksofexposureto300ppm
ETh, theratioofHEtVal:7-HEG increasedbyafactorof1.8-2.6,
depending on the tissue. With additional exposures, the ratio
should continue to increase as HEtVal accumulates over the
lifetimeoftheraterythrocyte. Duringexposuresequivalenttoor
exceedingtheRBClifespan, hemoglobinadductconcentrations
wouldreachaplateauandtheHEtVal:7-HEGratiowouldfinal-
ly become constant.
In contrast to the curves for rats, the shapes ofthe formation
curvesforHEtValand7-HEGinmiceexposedto 100ppmETO
suggested that hemoglobin adduct concentrations would ap-
proach a steady state shortly after DNA adductconcentrations
had plateaued in mouse lung (Fig. 3B). However, accurate
predictionsofthetimestosteadystatefor7-HEGinothermouse
tissueswill requirebettercharacterization ofthekineticsofDNA
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FIGURE 3. Formation ofN-(2-hydroxyethyl)valine in hemoglobin and 7-(2-
hydroxyethyl)guanine in DNAofrats (A)exposed to 300 ppmethylene ox-
ide and mice (B) exposed to 100 ppm ethylene oxide for up to 4 weeks (6
hr/day, 5days/week). Globin([), brain(A), lung(0), leukocytes(*), spleen
(-), kidney (0), liver(A), testis (X). Datapoints are means ± SE (n = 4
or5). Notethatthe scaleofthe Y-axes forA areadjusted sothatthedatapoints
forN-(2-hydroxyethyl)valine and7-(2-hydroxyethyl)guanine overlaponday
I ofexposure.
with published experiments showing that 4-aminobiphenyl
hemoglobin adductaccumulated inaparabolic fashionoverthe
life spanoftheerythrocyte(30), whichis66daysintheF344rat
(31). In comparison, the shapes of the formation curves for
7-HEG in rattissues suggested thatthis DNAadductshouldap-
proach steady-stateconcentrationsby4weeksofETOexposure.
Figure3A showsthattheratiooftheconcentrationsofHEtVal in
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FIGURE 4. Comparison ofthe projected loss ofN-(2-hydroxyethyl)valine to
theobserved lossofadductafter4 weeksofexposureofrats (A) to 300 ppm
ethylene oxide and mice (B) to 100 ppm ethylene oxide. Projected (0,0);
observed(0,0). Datapoints are means ± SE (n =5). Thederivation ofthe
curves for the projected loss ofN-(2-hydroxyethyl)valine is discussed in
Walker et al. (23) and Fennell et al. (28).
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350 accumulation shouldplateau after 9 weeks ofET() exposure.
Insummary, thesedatademonstratethattherelationshipsbe-
300 tweenhemoglobin and DNA adductaccumulation canchange
over time during repeated or intermittent exposures to elec-
trophiles, with thedegreeofchangedepending onsuch factors
250 as the pattern and duration ofexposures, cell kinetics, and the
stabilityoftheadducts understudy. Asillustratedbythefigures
200 comparing the formation (Fig. 3) and dose-response (Fig. 6) curvesforHEtValand7-HEGinETO-exposed ratsandmice, the
A 400
Z_300
0
-J
a cm
E
z200
Lu
I
E100
35
30
25
20
15
10
FIGURE 5. Persistence of7-(2-hydroxyethyl)guanine in DNAafter4weeks of
exposure of rats (A) to 300 ppm ethylene oxide and mice (B) to 100 ppm
ethylene oxide. Brain(A), lung(0), leukocytes(*), spleen(U), kidney (@),
liver (A), testis (X). Data points are means ± SE (n = 3 to 5).
adductremovalduring exposuresofmicetolowerconcentrations
ofETO. Nevertheless, the ratiooftheconcentrations ofHEtVal
and 7-HEG changed throughout repeated exposures ofmice to
100 ppm ET1O. Over the 4weeks ofexposure, the ratio ofHEt-
Val:7-HEG increased by a factor of2.5-4.2, depending on the
tissue.
Duringrepeated exposures toETO, thereshouldalsobetissue-
dependent differences in the relationship between HEtVal and
7-HEGduetotissuedifferences inDNArepair. Forexample, the
half-lives for 7-HEG in various rat tissues (Fig. 5A) indicated
that, during exposures that do not saturate repair, the adduct
should reach asteady stateby 2 weeks in leukocytes and spleen
compared to3-4 weeks inothertissues. As notedabove, HEtVal
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FIGURE 6. Comparison ofthe dose response forN-(2-hydroxyethyl)valine in
hemoglobin and7-(2-hydroxyethyl)guanine inDNAofrats(A) andmice (B)
exposed toethyleneoxidefor4weeks (6hr/day, 5 days/week) . Globin (O),
brain (A), lung (0), spleen (U). Datapoints are means ± SE (n = 3 to 5).
Note thatthe scaleofthe X-axis is different inA and Bandthat the scale of
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natureofthenonconstantrelationshipbetweenthehemoglobin
and DNA adducts can be both tissueand speciesdependent.
ImplicationsforHuman Biomonitoring
In human biomonitoring, quantitative analysis ofDNA and
hemoglobinadducts serves tworelatedgoals, assessmentofthe
internal doseandevaluationoftheeffectsproducedintargetcells
by a putative carcinogen (29). The results of the molecular
dosimetry studies in rats and mice exposed to ETO have con-
firmedcertainprinciplesconcerningrelationshipsbetweenDNA
and hemoglobin adducts and their use in exposure monitoring
and risk assessment (18,29).
First, these data demonstrate that considerable knowledge
concerning thestability and repairofDNAadducts indifferent
tissuesandatdifferentexposure concentrations isneededbefore
anypredictions canbemadefromDNAbiomonitoringdatafrom
exposed people. Thus far, noinformation isavailableconcern-
ing the formation and removal of7-HEG from DNA ofETO-
exposed people or ETO-treated human tissues.
Second, thekineticsofhemoglobinadductremovalfollowing
intermittentandvariableexposuresaremuch morecomplexthan
those associated with single or continuous exposures (23,28).
Thepatternofhemoglobin adductremoval canbecomplicated
further by exposures that influence erythrocyte life span or
erythropoiesis. As a possible example, chronic exposure to
tobacco smoke could induce mild, cumulative toxic effects in
erythrocytes and explain, in part, the faster-than-expected
decline in 4-aminobiphenyl hemoglobin (4ABP-Hb) adducts
seen in smokers enrolled in a withdrawal program(32). In the
first3 weeksofwithdrawal, therateofadductdeclinewasmost
compatible with an erythrocyte life span of80 days, compared
tothenormallifespanof120days. Maclureandco-workers (32)
suggested thatsomedegradation of4ABP-Hbadductmightoc-
cur over time, but it is also possible that the life span oferyth-
rocyteswas reduced insmokersduetothecombinedalkylating
potency of such tobacco constituents as ETO, acrylonitrile,
4-aminobiphenyl, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK). Compensatory erythropoiesis in these
smokers would certainly be sufficient to maintain normal red
blood cell counts and could be evaluated by assaying for
reticulocytes. Therefore, appropriate information onthepattern
ofexposures and red blood cell integrity should be considered
essential when assessing the significance of adduct values
obtained in monitoring humans exposed to hemoglobin
alkylating agents.
Third, duetodifferences information, persistence, repair, and
chemical depurination of7-HEG and toxicokinetic effects on
erythrocytes, therelationships between7-HEGandHEtVal con-
centrations willvarywithlengthofexposure, interval sinceex-
posure, species and tissue or even cell type. Thus, it appears
unlikely thatHEtValadductsinhemoglobinwillprovideaccurate
predictionsofDNAadducts inspecifictissuesofhumansunder
conditionswhereactualexposurescenariosareunknown. Ifthe
exposure conditions are known, the HEtVal and exposuredata
could be incorporated into a computer model to describe the
kineticsofaccumulationandremovalofadductsformedin vivo
in complex exposure scenarios. Fennell and co-workers (28)
haverecentlydevelopedsuchacomputermodelfortheformation
and removal ofhemoglobin adducts. Extension ofthis type of
model toincludedelineationsofDNArepair/losskinetics ofad-
ducts in human tissues and cells could provide a means of
estimating genetic damage in exposed individuals using DNA
and/orhemoglobinadductmeasurements. Limiteddatafromrat
studies have already been incorporated into a preliminary
physiologically basedpharmacokinetic model forsimulationof
ETO adductconcentrations in the rat (33).
Littleiscurrentlyknownabouttherelationshipbetween7-HEG
and the induction ofmutations and cancer by ETO. Although
similarconcentrations of7-HEGhavebeen foundintargetand
nontarget tissues ofrats and mice after single ET3O exposures
(19-21) and multiple exposures that saturated DNA repair
(22,24), thetissue-dependentvariationinthehalf-lifeforthisad-
ductindicatesthattherewillbespecies,tissue, andevencelldif-
ferencesintheextentof7-HEGaccumulationduringmultipleex-
posurestolowerconcentrationsofETO. However,othercritical
factorsappeartobeinvolvedinthespeciesandtissuespecificity
fortumorinductionbythischemical. Forinstance, thelocation
oflesions in the genome and tissue susceptibility or resistance
genesrepresentimportantdeterminantsthatcouldquantitative-
lyaffectthedose-responserelationshipforET1-inducedtumor-
igenesis. Identificationoftheseeventsandtheirrelationshipsto
7-HEGorHEtVal will requireadditional research.
This manuscript was presented at the Conference on Biomonitoring and
Susceptibility Markers inHumanCancer: Applications in Molecular Epidem-
iologyandRiskAssessmentthatwasheldinKailua-Kona, Hawaii, 26October-l
November 1991.
TheauthorsthankTracey Burns (University ofNorthCarolina) forassisting
in the preparation ofthis manuscript.
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